Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Rznomics brings RNA editing into Lilly’s San Diego biotech hub
5+ day, 22+ hour ago (412+ words) Biotech real estate has its own hierarchy, and San Diego sits near the top. So when a Seongnam-based RNA therapeutics company buys itself a desk inside Eli Lilly’s newest innovation outpost there, it’s worth asking what that access is actually…...
ARPA-H allots $125M to boost manufacturing for bespoke genetic medicines
1+ week, 5+ day ago (12+ words) FirstWord Pharma...
Morgan Stanley: Why Waters could emerge as the biggest winner from China’s new lab pricing rules
1+ week, 6+ day ago (1324+ words) The framework covers 662 main items, 114 add-ons and seven extensions. Although provincial authorities will ultimately decide the prices and implementation schedules in Chinese yuan, Morgan Stanley believes the final structure is broadly constructive for Waters' clinical mass spectrometry and microbiology businesses....
To outcompete China, unhandcuff America’s biotech innovators
3+ week, 4+ day ago (183+ words) by David Mansdoerfer, opinion contributor 08/20/26 11:30 AM ET America’s long-held dominance in biotechnology is slowly slipping away. China now conducts more clinical drug trials than the U.S., and its share of global drug-development activity has grown dramatically over the past decade....